Drug Type Small molecule drug |
Synonyms- |
Target |
Action blockers, inhibitors |
Mechanism CACNA2D2 blockers(Voltage-gated calcium channel alpha2/delta subunit 2 blockers), COX inhibitors(Cyclooxygenases inhibitors), Cav2.2 blockers(Voltage-gated N-type calcium channel alpha-1B subunit blockers) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC14H14O3 |
InChIKeyCMWTZPSULFXXJA-VIFPVBQESA-N |
CAS Registry22204-53-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoarthritis | Phase 2 | - | - | |
Toothache | Phase 2 | - | - |